Sotera Health Revises FY23 Revenues Guidance To $1.035B-$1.055B From Previous Guidance Of $1.055B-$1.090B Vs. Consensus Of $1.07B; Reaffirms Adjusted EPS Of $0.78-$0.86 Vs. Consensus Of $0.80
Portfolio Pulse from Benzinga Newsdesk
Sotera Health has revised its FY23 revenue guidance to $1.035B-$1.055B, down from the previous guidance of $1.055B-$1.090B. However, the company reaffirmed its adjusted EPS of $0.78-$0.86. The consensus estimates were $1.07B for revenue and $0.80 for EPS.
August 04, 2023 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sotera Health's revised FY23 revenue guidance is lower than previously stated, which could negatively impact investor sentiment. However, the reaffirmed EPS might mitigate some of this impact.
Lower revenue guidance often leads to negative investor sentiment as it indicates potential future underperformance. However, the reaffirmed EPS, which is in line with consensus estimates, might help to maintain some investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100